Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3922825 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL3921506 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL10382688 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL3919111 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL16431765 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL1543475 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL9008316 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL593055 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL22400862 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL28619360 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104109118-B | Adjacent pyridine hydrazide derivatives and its preparation method and pharmaceutical composition and purposes | 中国医学科学院药物研究所 | 2018-07-24 | — | — | CN | claimed |
| CN-104109118-A | O-pyridine hydrazide derivatives, and preparation methods, pharmaceutical composition and application thereof | INST MATERIA MEDICA CAMS | 2014-10-22 | — | — | CN | claimed |
| US-6726915-B2 | DIAMIDE COMPOUNDS RETAINING GOOD COSMETIC PROPERTIES, IN PARTICULAR A CERTAIN LEVEL OF | L'OREAL (FR) | 2004-04-27 | — | — | US | claimed |
| US-20030129211-A9 | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | L'OREAL S.A. (FR) | 2003-07-10 | — | — | US | claimed |
| CN-1386063-A | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | OREAL (FR) | 2002-12-18 | — | — | CN | claimed |
| US-20020150602-A1 | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | LIVOREIL AUDE (FR) | 2002-10-17 | — | — | US | claimed |
| WO-2002005763-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION IN SOLID FORM COMPRISING BIS-ACYL-AMIDES | L'OREAL (FR) | 2002-01-24 | — | — | WO | claimed |
| EP-1174110-A1 | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | L'OREAL (FR) | 2002-01-23 | — | — | EP | claimed |
| US-20240059881-A1 | OLEFIN RESIN COMPOSITION AND MOLDED BODY CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-22 | — | — | US | disclosed |
| EP-4279544-A1 | OLEFIN RESIN COMPOSITION AND MOLDED BODY CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-22 | — | — | EP | disclosed |
| CN-104109118-B | Adjacent pyridine hydrazide derivatives and its preparation method and pharmaceutical composition and purposes | 中国医学科学院药物研究所 | 2018-07-24 | — | — | CN | disclosed |
| EP-2939659-B1 | HAIR CLEANSING COMPOSITION | KAO CORP (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-9938406-B2 | Polylactic acid resin sheet for thermal molding use | KAO CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| CN-104684539-B | Detergent composition comprising sulfonate surfactant and/or sulfate anionic surfactant, and heterocyclic compound | 味之素株式会社 | 2018-02-27 | — | — | CN | disclosed |
| US-4186267-A | LIGHT STABILIZERS FOR POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-4166066-A | DISPERSING AGENTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-08-28 | — | — | US | disclosed |
| US-4163749-A | Dispersing agents | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-08-07 | — | — | US | disclosed |
| US-4157266-A | ADDUCT OF A POLYISOCYANATE, A POLYOL, AND AN ISOCYANATE-REACTIVE ESTER OR AMIDE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-06-05 | — | — | US | disclosed |
| US-4046788-A | ORTHO- OR PARA-HYDROXYBENZOATE ANIONS, AMINE LIGAND | CIBA-GEIGY CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-3948852-A | Nickel stabilisers for synthetic polymers | CIBA-GEIGY CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129211-A9 | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | FAAH, HRH1, HRH4 | FFAR1 59/4885FFAR4 118/4885GPR84 163/4885 |
| US-20020150602-A1 | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | FAAH, HRH1, HRH4 | FFAR1 59/4885FFAR4 118/4885GPR84 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.